Literature DB >> 15959721

Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of I(Ca,L).

Torsten Christ1, Erich Wettwer, Ursula Ravens.   

Abstract

The neuroleptic risperidone is an effective blocker of the rapidly activating component of the delayed rectifier current (I(Kr)) and hence is expected to prolong cardiac action potential duration (APD). However, unlike with other typical I(Kr) blockers we failed to demonstrate a marked prolongation of late repolarization with risperidone. It is hypothesized that the APD-prolonging effect of risperidone is masked by the high repolarization reserve due to the prominent delayed rectifier currents I(Kr) and I(Ks) in guinea pig papillary muscle. Action potentials and force of contraction were recorded in isolated guinea pig papillary muscles. L-type calcium current I(Ca,L) and I(Kr) were measured using the standard patch clamp technique in single ventricular cardiomyocytes. Reduction of the repolarization reserve by the blocking of I(Ks) with chromanol 239B augmented the effect of the selective I(Kr) blocker E-4031, but not of risperidone, although both drugs completely blocked I(Kr). In contrast to E-4031 risperidone markedly reduced the force of contraction due to the partial blocking of I(Ca,L) in the same concentration range as required for block of I(Kr). Reduction of the repolarization reserve by the blocking of I(Ks) cannot exacerbate the APD-prolonging effect of risperidone. However, even incomplete concomitant blocking of I(Ca,L) attenuates the APD-prolonging effect of the complete blocking of I(Kr). This behaviour may explain the small APD-prolonging effect of risperidone despite the drug's robust blocking of I(Kr).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15959721     DOI: 10.1007/s00210-005-1063-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

Review 1.  Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs.

Authors:  J Weirich; H Antoni
Journal:  Basic Res Cardiol       Date:  1998       Impact factor: 17.165

Review 2.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.

Authors:  D M Roden; R Lazzara; M Rosen; P J Schwartz; J Towbin; G M Vincent
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

3.  KVLQT channels are inhibited by the K+ channel blocker 293B.

Authors:  M Bleich; M Briel; A E Busch; H J Lang; U Gerlach; H Gögelein; R Greger; K Kunzelmann
Journal:  Pflugers Arch       Date:  1997-08       Impact factor: 3.657

4.  Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block.

Authors:  A Ohler; G J Amos; E Wettwer; U Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

Review 5.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

Authors:  A H Glassman; J T Bigger
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

Review 6.  Drug-induced torsade de pointes: from molecular biology to bedside.

Authors:  J Tamargo
Journal:  Jpn J Pharmacol       Date:  2000-05

Review 7.  Effects of risperidone in overdose.

Authors:  A A Acri; F M Henretig
Journal:  Am J Emerg Med       Date:  1998-09       Impact factor: 2.469

8.  Overdose of risperidone.

Authors:  K Brown; H Levy; C Brenner; S Leffler; E L Hamburg
Journal:  Ann Emerg Med       Date:  1993-12       Impact factor: 5.721

9.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

10.  New Generation Antipsychotic Drugs and QTc Interval Prolongation.

Authors:  W VictorR Vieweg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-10
View more
  7 in total

1.  Inhibition of cloned hERG potassium channels by risperidone and paliperidone.

Authors:  Hong Joon Lee; Jin-Sung Choi; Bok Hee Choi; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-03-06       Impact factor: 3.000

2.  Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.

Authors:  Gerrit Frommeyer; Henning von der Ahe; Benedict Brücher; Dirk G Dechering; Philipp S Lange; Florian Reinke; Kristina Wasmer; Julia Köbe; Christian Pott; Gerold Mönnig; Lars Eckardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-12       Impact factor: 3.000

3.  Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.

Authors:  László Szabó; Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Ferenc Ruzsnavszky; Krisztina Váczi; Balázs Horváth; János Magyar; Tamás Bányász; Balázs Pál; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-19       Impact factor: 3.000

4.  Electrophysiological profile of propiverine--relationship to cardiac risk.

Authors:  Torsten Christ; Erich Wettwer; Melinda Wuest; Manfred Braeter; Frank Donath; Pascal Champeroux; Serge Richard; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

5.  L-364,373 fails to activate the slow delayed rectifier K+ current in canine ventricular cardiomyocytes.

Authors:  János Magyar; Balázs Horváth; Tamás Bányász; Norbert Szentandrássy; Péter Birinyi; András Varró; Zsolt Szakonyi; Ferenc Fülöp; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-17       Impact factor: 3.000

6.  Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS.

Authors:  Paul Kreifels; Ilona Bodi; Tibor Hornyik; Gerlind Franke; Stefanie Perez-Feliz; R Lewetag; Robin Moss; Alessandro Castiglione; David Ziupa; Manfred Zehender; Michael Brunner; Christoph Bode; Katja E Odening
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-03

7.  Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.

Authors:  Attila Kristóf; Zoltán Husti; István Koncz; Zsófia Kohajda; Tamás Szél; Viktor Juhász; Péter Biliczki; Norbert Jost; István Baczkó; Julius Gy Papp; András Varró; László Virág
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.